Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Alopecia areata affects quality of life more in adolescents than adults.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Higher IL-17A levels indicate more severe alopecia areata.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Siddha medicine helped a child regrow hair lost from alopecia areata.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Nail changes are common in alopecia areata and can indicate its severity.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.